A detailed history of Atwood & Palmer Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Atwood & Palmer Inc holds 581 shares of NVO stock, worth $79,597. This represents 0.01% of its overall portfolio holdings.

Number of Shares
581
Previous 400 45.25%
Holding current value
$79,597
Previous $51,000 60.78%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$122.71 - $146.91 $22,210 - $26,590
181 Added 45.25%
581 $82,000
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $13,167 - $15,817
150 Added 60.0%
400 $41,000
Q3 2023

Oct 20, 2023

BUY
$90.94 - $199.54 $22,735 - $49,885
250 New
250 $22,000
Q4 2017

Feb 08, 2018

SELL
$47.53 - $53.73 $209,132 - $236,412
-4,400 Closed
0 $0
Q3 2017

Oct 16, 2017

SELL
$41.15 - $49.22 $26,747 - $31,993
-650 Reduced 12.87%
4,400 $212,000
Q2 2017

Aug 08, 2017

BUY
N/A
5,050
5,050 $217,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $309B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Atwood & Palmer Inc Portfolio

Follow Atwood & Palmer Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.